Héroux-Devtek Temettü

Temettü kriter kontrolleri 0/6

Héroux-Devtek şirketinin temettü ödeme geçmişi bulunmamaktadır.

Anahtar bilgiler

n/a

Temettü verimi

0.5%

Geri Alım Getirisi

Toplam Hissedar Getirisi	0.5%
Gelecekteki Temettü Verimi	n/a
Temettü Büyümesi	n/a
Bir sonraki temettü ödeme tarihi	n/a
Eski temettü tarihi	n/a
Hisse başına temettü	n/a
Ödeme oranı	n/a

Son temettü güncellemeleri

Güncelleme yok

Recent updates

Héroux-Devtek Inc. (TSE:HRX) Stock Rockets 28% As Investors Are Less Pessimistic Than Expected

Jun 08

Investors Shouldn't Be Too Comfortable With Héroux-Devtek's (TSE:HRX) Earnings

May 29

What Is Héroux-Devtek Inc.'s (TSE:HRX) Share Price Doing?

May 23

Results: Héroux-Devtek Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts

Feb 10

Results: Héroux-Devtek Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates

Nov 18

Ödemelerde İstikrar ve Büyüme

Temettü verilerini getirme

İstikrarlı Temettü: HRX şirketinin hisse başına düşen temettülerinin geçmişte istikrarlı olup olmadığını belirlemek için yeterli veri yok.

Büyüyen Temettü: HRX şirketinin temettü ödemelerinin artıp artmadığını belirlemek için yeterli veri yok.

Piyasaya Karşı Temettü Getirisi

Héroux-Devtek Piyasaya Karşı Temettü Getirisi

HRX temettü verimi piyasa ile karşılaştırıldığında nasıldır?
Segment	Temettü Verimi
Şirket (HRX)	n/a
Pazarın Alt %25'i (CA)	1.8%
Pazarın En İyi %25'i (CA)	6.2%
Sektör Ortalaması (Aerospace & Defense)	1.5%
Analist tahmini (HRX) (3 yıla kadar)	n/a

Önemli Temettü: HRX şirketinin temettü getirisi, şirketin yakın zamanda herhangi bir ödeme bildirmemesi nedeniyle, temettü ödeyenlerin en alttaki %25'lik dilimine göre değerlendirilemiyor.

Yüksek Temettü: Şirketin yakın zamanda herhangi bir ödeme bildirmemesi nedeniyle, HRX şirketinin temettü getirisi, temettü ödeyenlerin en üst %25'ine göre değerlendirilemiyor.

Hissedarlara Ödenen Kazanç

Kazanç Kapsamı: HRX şirketinin temettü ödemelerinin kazançlarla karşılanıp karşılanmadığını belirlemek için ödeme oranını hesaplamak üzere yeterli veri yok.

Hissedarlara Nakit Ödeme

Nakit Akışı Kapsamı: HRX herhangi bir ödeme bildirmediğinden temettülerin sürdürülebilirliği hesaplanamıyor.

Héroux-Devtek Temettü

Temettü kriter kontrolleri 0/6

Anahtar bilgiler

Son temettü güncellemeleri

Recent updates

Héroux-Devtek Expects to Delist from TSX

Consensus EPS estimates increase by 17%

First quarter 2025 earnings: EPS and revenues exceed analyst expectations

Investor sentiment improves as stock rises 23%

Platinum Equity, LLC, Gilles Labbé, Martin Brassard entered into an arrangement agreement to acquire Héroux-Devtek Inc. (TSX: HRX) from Caisse de dépôt et placement du Québec, Gilles Labbé, Martin Brassard and others in an equity reinvestment transaction for CAD 1.1 billion.

Héroux-Devtek Inc. (TSE:HRX) Stock Rockets 28% As Investors Are Less Pessimistic Than Expected

Investors Shouldn't Be Too Comfortable With Héroux-Devtek's (TSE:HRX) Earnings

Consensus EPS estimates increase by 21%

Full year 2024 earnings: EPS and revenues exceed analyst expectations

What Is Héroux-Devtek Inc.'s (TSE:HRX) Share Price Doing?

Héroux-Devtek Inc., Annual General Meeting, Aug 06, 2024

Héroux-Devtek Inc. to Report Q4, 2024 Results on May 22, 2024

Price target increased by 7.5% to CA$24.50

Results: Héroux-Devtek Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts

Third quarter 2024 earnings: EPS and revenues exceed analyst expectations

Is Now The Time To Look At Buying Héroux-Devtek Inc. (TSE:HRX)?

Consensus EPS estimates increase by 26%

Price target increased by 7.3% to CA$20.70

Héroux-Devtek Inc. to Report Q3, 2024 Results on Feb 07, 2024

Second quarter 2024 earnings: EPS and revenues miss analyst expectations

Héroux-Devtek Inc. to Report Q2, 2024 Results on Nov 10, 2023

New major risk - Financial position

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

Now 20% undervalued

Héroux-Devtek Inc., Annual General Meeting, Aug 08, 2023

Now 20% undervalued

Full year 2023 earnings: EPS and revenues exceed analyst expectations

Consensus EPS estimates fall by 40%

Third quarter 2023 earnings: Revenues in line with analyst expectations

Consensus EPS estimates fall by 42%

At CA$16.20, Is Héroux-Devtek Inc. (TSE:HRX) Worth Looking At Closely?

Investor sentiment improves as stock rises 16%

Héroux-Devtek Inc. to Report Q3, 2023 Results on Feb 08, 2023

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

Héroux-Devtek Inc. to Report Q2, 2023 Results on Nov 11, 2022

Consensus EPS estimates fall by 28%

Price target decreased to CA$21.80

First quarter 2023 earnings: EPS and revenues miss analyst expectations

Héroux-Devtek Inc. to Report Q1, 2023 Results on Aug 05, 2022

Insider exercised options to buy CA$74k worth of stock.

CFO & VP recently sold CA$383k worth of stock

Héroux-Devtek Inc., Annual General Meeting, Aug 05, 2022

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Consensus EPS estimates fall by 13%

Third quarter 2022 earnings: EPS and revenues miss analyst expectations

Now 23% undervalued after recent price drop

President exercised options to buy CA$568k worth of stock.

Second quarter 2022 earnings released: EPS CA$0.21 (vs CA$0.11 in 2Q 2021)

Executive Chairman of the Board exercised options to buy CA$325k worth of stock.

First quarter 2022 earnings released: EPS CA$0.19 (vs CA$0.038 loss in 1Q 2021)

President exercised options to buy CA$188k worth of stock.

Is It Time To Consider Buying Héroux-Devtek Inc. (TSE:HRX)?

We Like Héroux-Devtek's (TSE:HRX) Earnings For More Than Just Statutory Profit

Full year 2021 earnings released: EPS CA$0.55 (vs CA$1.38 loss in FY 2020)

Price target increased to CA$22.00

Calculating The Fair Value Of Héroux-Devtek Inc. (TSE:HRX)

Is Héroux-Devtek (TSE:HRX) Using Too Much Debt?

New 90-day high: CA$16.46

Our Take On The Returns On Capital At Héroux-Devtek (TSE:HRX)

This Insider Has Just Sold Shares In Héroux-Devtek Inc. (TSE:HRX)

Héroux-Devtek Inc. Appoints Didier Evrard as Director

Third quarter 2021 earnings released: EPS CA$0.24 (vs CA$0.24 in 3Q 2020)

Revenue and earnings beat expectations

Price target raised to CA$18.83

New 90-day high: CA$15.40

Is There Now An Opportunity In Héroux-Devtek Inc. (TSE:HRX)?

A Look At The Intrinsic Value Of Héroux-Devtek Inc. (TSE:HRX)

Héroux-Devtek Inc. to Report Q3, 2021 Results on Feb 05, 2021

New 90-day high: CA$14.94

A Look At Héroux-Devtek's (TSE:HRX) Share Price Returns

What You Need To Know About Héroux-Devtek Inc.'s (TSE:HRX) Investor Composition

How Much Are Héroux-Devtek Inc. (TSE:HRX) Insiders Spending On Buying Shares?

Results: Héroux-Devtek Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates

Price target raised to CA$16.33